Table 2.

Obstetric & gynaecological characteristics of 3rd trimester pregnant women, including the dosing of IPTp-SP and FA.

Variable	Full sample		Urban		Rural
	N = 697	%	N = 353	%	N = 344	%
Gravidity
Gravida 1	174	24.9	108	30.6	66	19.2
Gravida 2 or more	523	75.1	245	69.4	278	80.8
Gestational age at first ANC contact
≤12 weeks	218	31.2	100	28.3	118	34.3
>12 to 24 weeks	436	62.6	230	65.2	206	59.9
≥25 weeks	43	6.2	23	6.5	20	5.8
Gestational age (on the day of interview)
25–30 weeks	405	58.1	211	59.8	194	56.4
31–36 weeks	230	33.0	113	32.0	117	34.0
37–42 weeks	62	8.9	29	8.2	33	9.6
Parity
Nulliparous	183	26.2	115	32.6	68	19.8
Primiparous	172	24.7	104	29.5	68	19.8
Multiparous	327	46.9	131	37.1	196	56.9
Grand multiparous (≥5)	15	2.2	3	0.8	12	3.5
ANC contacts
1	25	3.6	12	3.4	13	3.8
2	24	3.4	13	3.7	11	3.2
3	97	13.9	58	16.4	39	11.3
4	192	27.6	93	26.4	99	28.8
5	126	18.1	66	18.7	60	17.4
6	106	15.2	58	16.4	48	14.0
7	112	16.1	48	13.6	64	18.6
8	15	2.1	5	1.4	10	2.9
Reason for missed SP doses (only those who had ≤SP2)
Missed ANC schedule	52	24.0	21	17.1	30	31.9
SP Shortage at facility	73	33.6	24	19.5	47	50.0
Others (‘not eaten’, staff absenteeism, sickness)	92	42.4	78	63.4	17	18.1
Number of SP doses taken for current pregnancy
None (0)	9	1.3	5	1.4	4	1.2
SP1	35	5.0	15	4.2	20	5.8
SP2	173	24.8	103	29.2	70	20.3
SP3	184	26.5	96	27.2	88	25.6
SP4	177	25.4	80	22.7	97	28.2
SP5	100	14.3	47	13.3	53	15.4
SP6	19	2.7	7	2.0	12	3.5
Administered SP & 5 mg Folic Acid (FA)
Yes	549	78.8	295	83.6	254	73.8
No	148a	21.2	58a	16.4	90a	26.2

^aIndicated that FA was not taken on the day of the ANC contact. There is no scientific evidence of how long apart SP should be withheld if 5 mg FA is given, even though 2 weeks is suggested (WHO, 2014).